DUBLIN--(BUSINESS WIRE)--The "Global Facial Injectables Market, By Type, By Application, By End-user & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The Global Facial Injectables market was valued at USD 16.1 Billion in 2021, and it is expected to reach a value of USD 29.62 Billion by 2028, at a CAGR of more than 9.1% over the forecast period (2022- 2028).
Facial injectables are injected into specific facial areas to enhance the look of the skin. These injectables, which help in skin suppleness restoration, are frequently made using collagen, hyaluronic acid, and calcium hydroxylapatite. They are used to fill up lips and wrinkles, elevate sunken scars, and accentuate shallow features. Facial injectables are becoming increasingly popular throughout the world because to their safety, affordability, and minimal downtime. With age, collagen synthesis and fat deposition under the skin decline, making the skin more prone to wrinkles and sagging. This, along with the growing elderly population and the desire to retain young and healthy skin, is one of the major factors driving market growth.
Drivers
Environmental contaminants and a variety of lifestyle choices cause skin damage, which drives up demand throughout the forecast period. Collagen fibres, hyaluronic acid fillers, and synthetic fillers make up facial injectables. This lotion moisturizes and beautifies the skin while protecting it from UV damage and has little side effects. In addition, non-surgical market treatments, face injectable fillers, and wrinkle relaxers have tripled in recent years. Non-invasive aesthetic procedures will boost the market throughout the forecast period. All of the previously listed reasons have an impact on the growth of the face injectable market.
Restraint
Strict regulatory considerations and product constraints, as well as skin issues such as rashes and redness, hinder expansion. Rather than aesthetic applications, many market barriers are inhibiting growth throughout the forecast period. Filler costs are too expensive, limiting expansion and, as a result, market size. Another important problem restricting the expansion of the face injectable sector is the harmful effects of dermal injectables.
Market Trend
A surge in male population utilization of face injectables is one of the market's important developments. Throughout the projected period, this specific trend is likely to contribute positively to market growth. Throughout the projection period, the male population is likely to use a variety of fillers, including botulinum toxin and dermal fillers. For example, an increasing number of young men are turning to tissue fillers before their skin begins to droop. It may be feasible to greatly delay the creation of wrinkles by increasing volume and plumping up the skin. The use of proper face injectables, which may assist restore lip fullness, will lessen the likelihood of developing new creases, wrinkles, and folds.
Companies Mentioned
- ALLERGAN (AbbVie, Inc.) (US)
- Ipsen Pharma (France)
- USWM, LLC (WorldMeds) (US)
- Revance Therapeutics, Inc. (US)
- Merz Pharma (Germany)
- GALDERMA (Switzerland)
- Sinclair Pharma (UK)
- BIOPLUS CO., LTD. (South Korea)
- Bioxis Pharmaceuticals (France)
- Anika Therapeutics, Inc. (US)
For more information about this report visit https://www.researchandmarkets.com/r/i77kkz
